SUMMARY
Previous observations from our laboratory have stressed the importance of intrarenal betaadrenergic receptors in mediating the stimulatory effect of catecholamines on renin secretion in the isolated perfused rat kidney (Vandongen, Peart & Boyd, 1973) . The response in renin secretion to isoproterenol, which has largely beta-adrenergic activity, was the striking feature but the marked augmentation of the response in renin secretion to noradrenaline, observed in several instances when the alpha-receptors were blocked with phenoxybenzamine, suggested a possible inhibitory effect of alpha-adrenergic activity on renin secretion. Such an inhibitory effect on renin secretion is also shown by vasopressin (Bunag, Page & McCubbin, 1967; Vander, 1968) and angiotensin (Genest, It has been shown (Vandongen & Peart, 1974 ) that the inhibitory effect of angiotensin I1 on renin secretion, and its contractile effect on vascular smooth muscle, requires the presence of calcium. Since the contractile response to alpha-adrenergic agonists is also ultimately dependent on the availability of free calcium (Somlyo & Somlyo, 1968) , it is conceivable that an inhibitory effect on renin secretion could be similarly mediated.
The present study was initiated to define more precisely the role of the alpha-adrenergic receptor in the regulation of renin secretion.
MATERIALS A N D METHODS

Kidney perfusion
Male Wistar rats (300-400 g) maintained on a regular diet were anaesthetized with sodium pentobarbitone [0.4 pmol/g (0.1 mg/g)] given intramuscularly and heparinized (50-100 units intravenously). The left kidney was isolated and perfused without interruption of blood flow as previously described (Vandongen et al., 1973) . Krebs-Ringer saline (Ca, 3.7 mmol/l; K, 6 mmol/l; Mg, 1.2 mmol/l) with dextran 36 g/1 (mol. wt. 70,000; Pharmacia), oxygenated with O2 +COz (955) and maintained at 37"C, was used as the perfusion medium and delivered as pulsatile flow (usually 8 ml/min) by a roller pump (Watson-Marlow). In certain experiments, designated below, calcium was excluded from the Krebs-Ringer saline and disodium ethylenediamine tetra-acetate (EDTA) (25 mmol/l) was added. Perfusion pressure was continuously recorded by a transducer and Devices M2 recorder. Mean perfusion pressure, initially high (150-250 mmHg), fell rapidly to a lower value (50-100 mmHg) within 5 min of commencing perfusion. At this point, designated 0 min, a control collection of effluent perfusate was obtained for determination of basal renin secretion. Adrenergic blocking agents (phenoxybenzamine, propranolol) or saline (0.16 mol/l NaCl) were infused immediately after the control collection and continued throughout the experimental period. A further collection during the infusion of blocking agents or saline was obtained at 3 min. The infusion of adrenergic agonists (isoproterenol, noradrenaline tartrate, methoxamine) was commenced at 4 min and continued for the duration of the experiment, with collections for renin determination being made at 6, 8 and 10 min. All pharmacological agents were diluted in 0.16 mol/l saline and infused into the renal arterial cannula at 0-04 ml/min. Doses are expressed per g wet kidney weight (non-perfused kidney).
Renin assay
Timed collections of perfusate were treated according to the method of Skinner (1967) for plasma renin activity. After incubation with nephrectomized rat plasma as renin substrate source (treated as sheep substrate by the method of Skinner), the samples were assayed without extraction for angiotensin I by radioimmunoassay (Boyd, Adamson, Fitz & Peart, 1969), as previously described (Vandongen et al., 1974) .
Renin concentration is expressed in nmol equivalents of Asp1-Ile' angiotensin I (AI) generated per ml of perfusate per 24 h incubation. Since flow rates did not remain constant when perfusion pressure exceeded 200 mmHg, as frequently occurred during the infusion of noradrenaline and methoxamine, renin values are expressed as secretion rates (renin concentration x flow rate) (mean SEM).
RESULTS
As shown in Table l(b), the vasoconstrictor effect of noradrenaline [2.37 nmol min-lg-' (0-4 p g min-l g-')I increased mean renal perfusion pressure and this persisted throughout the period of infusion. The increase in renin secretion observed cannot be attributed to noradrenaline as a similar increase with time was seen in experiments where saline only was infused for a similar period (Table la) .
When noradrenaline [2-37 nmol min-' g-' (0.4 pg min-' g-')] was added during the infusion of the alpha-adrenergic blocking agent phenoxybenzamine [4.0 nmol min-' g-' (1-2 pg min-' g-I)], a marked increase in renin secretion was observed (Table Ic) with levels significantly higher compared with the corresponding levels without phenoxybenzamine (Table 1 b) . Although the infusion of phenoxybenzamine alone for 3 min was associated with an increase in renin secretion (Table lc) , this was not significantly different from the 3 min level during saline infusion (Table 1 b). In three additional experiments, continuing the infusion of phenoxybenzamine alone for 10 min produced a further increase in renin secretion (60 k 5) but this was significantly less than the corresponding value in the presence of noradrenaline (Table lc) (P < 0.01). The vasoconstrictor action of noradrenaline was abolished by phenoxybenzamine and the mean renal perfusion pressure showed instead a significant fall during the combined infusion of these agents (Table lc) , reaching pressures similar to that seen during saline infusion (Table la) .
The addition of the beta-adrenergic blocking agent propranolol [31 nmol min-' g-' (8 pg min-' g-l)] to phenoxybenzamine [4.0 nmol min-' g-' (1.2 pg min-l g-')I substantially reduced the response in renin secretion to noradrenaline E2.37 nmol min-l g-' (0-4 pg min-' g-')I (Table Id) ; mean renal perfusion pressure decreased significantly during this period.
Compared with the renin response in the presence of calcium (3.7 mmol) (Table lb) , the infusion of noradrenaline [2.37 nmol min-' g-' (0.4 pg min-' g-')I when calcium was excluded from the perfusion medium (containing 25 mmol/l disodium EDTA) resulted in a prompt and large increase in renin secretion (Table le) , with levels higher at all times than during control calcium-free perfusion without noradrenaline (P< 0-01, n = 7). The percentage increase in renin secretion after noradrenaline was 37,47 and 11 3, in the presence of calcium For significance of difference in mean perfusion pressure from the 3 min values (paired Student's t-test): tP>0-05; ttP<O.05; tttP<O.Ol; t t t t P < 0001.
For signiscanCe of difference in mean renin secretion between (b) and (a), (c) and (b), (d) and (c), (e) (Table lc) . It should be noted at this point that, although noradrenaline did not increase perfusion pressure in the absence of calcium (Table le) , the gradual fall observed in Table l (a) and l(c) did not occur, suggesting some residual vasoconstrictor activity. As observed previously (Vandongen & Peart, 1974) , basal renin secretion was considerably higher in the absence of calcium (Table l a and le; mean renal perfusion pressures were similar under these conditions. Table 2 indicates that methoxamine [16 nmol rnin-l g-' (4pg min-' g-')I, an agent with exclusive alpha-adrenergic properties, does not stimulate renin secretion even after alphareceptor blockade with phenoxybenzamine [4-0 nmol min-' g-' (1-2 pg min-' g-')] (Table 2) , which prevented the increase in renal perfusion pressure. Renin secretion at 10 min was significantly less during the infusion of methoxamine and saline (5*5+0.4) (Table 2) than with saline alone (27.1 rl: 5-4) (Table la) (P<O.Ol). Since this difference is not apparentwhen methoxamine and phenoxybenzamine are infused concurrently (14.2 5 6.5) (Table 2) (P> 0.09, an inhibitory effect of alpha-receptor stimulation on the spontaneous release of renin is suggested. Similarly the renin response to isoproterenol[O.O5 nmol min-' g-' (0.01 pg min-' g-')I (Table  3a) , which has mostly beta-adrenergic activity, was considerably reduced when it was infused with methoxamine [16 nmol min-1g-1(4pg min-' g-l)] (Table 3b) , resulting in values which were not significantly different from those in Table 1 (a) (P> 0.05). Mean renal perfusion pressures showed a progressive and significant fall during the combined infusion of isoproterenol and methoxamine, yet were consistently higher than during infusion of isoproterenol and saline. Mean perfusion pressures during the infusion of isoproterenol and saline (Table 3a ) and infusion of saline only (Table la) were similar, whereas renin secretion was markedly different. 
DISCUSSION
The concept that adrenergic control of renin secretion is mediated by a direct effect of catecholamines on the renin-producing cell is well supported (Michelakis, Caudle & Liddle, 1969; Rosset & Veyrat, 1971). Evidence for the specific involvement of intrarenal beta-adrenergic receptors in the stimulation of renin secretion by isoproterenol in the rat kidney has been recently presented (Vandongen et al., 1973) . In this study a significant stimulatory effect of noradrenaline on renin secretion was also reported, although this was considerably less than for isoproterenol. It is now apparent from the extended observations reported here, employing the more sensitive radioimmunoassay instead of the bioassay for angiotensin I, that the rise in renin secretion during infusion of noradrenaline cannot be distinguished from the rising baseline secretion in control experiments. No explanation for the progressive rise in basal renin secretion is presently available. However, when noradrenaline was infused during alpha-receptor blockade, an increase in renin secretion occurred that was substantially above control values. As observed with isoproterenol, the stimulation of renin secretion cannot be attributed to the fall in renal perfusion pressure alone as a similar fall occurred in the control experiments. Attenuation of the renin response by propranolol is suggestive evidence that the effect of noradrenaline on renin secretion is mediated by beta-receptors. Although activation of beta-adrenergic receptors by noradrenaline stimulates renin secretion, it is apparent that this may be prevented by simultaneous alpha-receptor activity. Similarly it is evident that methoxamine, with exclusive alpha-receptor activity, can inhibit the response in renin secretion to beta-adrenergic receptor stimulation by isoproterenol. Since the contractile response of vascular smooth muscle to catecholamines is initiated through alpha-receptors, it is conceivable that both the contractile response and the inhibition of renin secretion are in some way related. Such a relationship between smooth muscle contractility and renin inhibition was also proposed for the action of angiotensin (Vandongen et al., 1974) . In this instance, however, renal vasoconstriction (and increased perfusion pressure) and renin inhibition appeared to be dissociated although both actions appeared to be calcium-dependent (Vandongen & Peart, 1974) . These findings are extended by the present investigation and suggest that the contractility and inhibition of renin secretion after alpha-adrenergic receptor activity may show a similar calcium-dependence. However, since vasoconstriction and renin inhibition were not clearly dissociated in all instances, a possible direct effect of raised perfusion pressure on renin secretion cannot be excluded.
It is conceivable that a similar relationship exists between smooth muscle relaxation, which is probably associated with a fall in free intracellular calcium (Schild, 1967; Somlyo & Somlyo, 1968; Seidel & Bohr, 1971) , and stimulation of renin secretion. Such a hypothesis is supported by the observation that two agents with renal vasodilator properties, namely isoproterenol (Carriere, 1969) and glucagon (Stowe &Hook, 1970) , also stimulate renin secretion (Vandongen et al., 1973) . Furthermore, blocking the alpha-receptor activity of noradrenaline with phenoxybenzamine, which augments renin secretion as shown in this study, also imparts a vasodilator effect to noradrenaline (Carriere, 1969) .
The evidence implicating adenosine 3'5'-cyclic monophosphate (cyclic AMP) in the relaxation response of vascular smooth muscle to beta-adrenergic stimulation is substantial (Robison, Butcher & Sutherland, 1971) , and a similar role for cyclic AMP in renin secretion has been suggested (Michelakis et al., 1969; Winer, Chokshi & Walkenhorst, 1971) . The observation that cyclic AMP reduces the concentration of free intracellular calcium in smooth muscle by promoting microsomal uptake and binding (Entman, Levey & Epstein, 1969; Shinebourne & White, 1970; Baudouin-Legros & Meyer, 1972 ) offers a possible mechanism by which the betaadrenergic effect of the catecholamines on renin secretion and smooth muscle relaxation are expressed. Conversely, since the contractile response to alpha-adrenergic stimulation and to angiotensin is accompanied by a rise in free intracellular calcium, and since both calcium (Volicer & Hynie, 1971 ) and angiotensin itself (Volicer & Hynie, 1971 ; d'Auriac, Baudouin & Meyer, 1972) have been shown to inhibit adenyl cyclase, it is conceivable that a reduction in amounts of intracellular cyclic AMP may be important in the inhibition of renin secretion by vasoconstrictor agents.
The probable importance of calcium in the regulation of renin secretion in the isolated kidney is indicated not only by the inhibitory effect of angiotensin (Vandongen & Peart, 1974) and noradrenaline, but also in the process which controls the spontaneous secretion of renin. Although the increase in basal renin secretion observed in calcium-free perfusions could be attributed to alterations in membrane properties, leading to an efflux of renin from intracellular stores, it is also conceivable that a more active calcium-dependent inhibitor is rendered ineffective under these conditions. Such a process limiting basal renin release could operate through locally formed angiotensin (Lever & Peart, 1962; Bailie, Rector & Seldin, 1971) .
It is of considerable interest that the opposing effects of alpha-and beta-adrenergic stimulation on renin secretion are also observed in relation to the action of catecholamines on insulin secretion (Porte, Graber, Kuzuya & Williams, 1966; Porte, 1967; Turtle, Littleton & Kipnis, 1967) and to the action of catecholamines on both the central release (Schrier & Berl, 1973) and renal action of vasopressin (Fisher, 1968; Klein, Liberman, Laks & Kleeman, 1971) . It is suggestive therefore that the basic mechanisms that mediate responses to adrenergic stimulation are common to a wide range of situations, with the individual response determined by the specialized nature of the cell stimulated. The morphological derivation of the juxtaglomerular cell from vascular smooth muscle (Barajas & Latta, 1967) provides in addition a structural basis for the relationship between renin secretion and contractile activity.
